7:15 - 8:00 a.m.

8:00 - 8:30 a.m.

8:30 - 9:30 a.m.

9:30 - 10:00 a.m.

10:00 - 11:30 a.m.

11:30 - Noon

Noon - 1 p.m.

Morning Session

Afternoon Session1:00 - 3:00 p.m.

Registration and Visit Exhibits

Breakout Sessions: How to Increase Colorectal Cancer Screening Rates in Practice Quality Care - Palliative Care in Cancer Cancer Survivorship: Plans, Physical and Mental Health Physical Activity Interventions at Worksite, School and Community Levels

Keynote Speaker: Richard Wender, MDChief Cancer Control OfficerIn 2006, Dr. Wender was elected as the national President of the American Cancer Society, becoming the first primary care physician to serve in this capacity. In November 2013, he became the Chief Cancer Control Officer of the American Cancer Society (ACS), Inc. and is charged with providing over-sight and guidance for the national and global cancer control programs of ACS. Dr. Wender currently serves as Chair of the National Colorectal Cancer Roundtable, an organization consisting of close to 80 organizations dedicated to eliminating colon cancer as a major public health problem.

Lunch and Visit Exhibits

North Dakota Cancer Coalition (NDCC) Business Meeting

Keynote Speaker

Morning Break to Visit Exhibits

Two Local Initiative Speakers to increase Colorectal Cancer Screening

Keynote Speaker - Wrap Up

Afternoon Break to Visit Exhibits

Subcontract Panel Presentation for Chronic Disease Prevention

Evaluation and Closing

Conference Agenda

3:00 - 3:15 p.m.

3:15 - 4:15 p.m.

4:15 - 4:40 p.m.

Colorectal Cancer Facts

What is colorectal cancer?

Colorectal cancer develops in the colon or rectum. The colon and rectum are parts of the digestive

system, also called the gastrointestinal, or GI, system. Colorectal cancer usually develops slowly over a

period of 10 to 15 years and typically begins as a non-cancerous polyp, a growth of tissue on the lining of

the colon or rectum.

Who gets colorectal cancer?

Anyone can get colorectal cancer. The lifetime risk of being diagnosed with colorectal cancer is about

five percent for persons in the US.

Age

Incidence and death rates for colorectal cancer increase with age. Overall 90 percent of new cases and

94 percent of deaths occur in individuals 50 and older.

Sex

Colorectal cancer incidence rates are about 35 to 40 percent higher in men than in women.

Race/Ethnicity

Colorectal cancer incidence and mortality rates are highest in African Americans; incidence rates are 20

percent higher and mortality rates about 45 percent higher than whites. In North Dakota, the incidence

rate for American Indians is about six percent higher than that of whites. However, it is important to

recognize that the burden of colorectal cancer varies greatly within racial/ethnic groups.

What are the risk factors for colorectal cancer?

People with a first-degree relative who has had colorectal cancer have two to three times the

risk of developing colorectal cancer

Personal history of colorectal cancer, adenomatous polyps, or chronic inflammatory bowel

disease

Other risk factors linked to colorectal cancer include physical inactivity, being overweight or

obese, having a poor diet, smoking, and consumption of alcohol

What are the recommended screening options for colorectal cancer?

Regular screening starting at age 50 is recommended for those of average risk. While there are several

tests available, the following high-quality tests are the most common:

Colonoscopy – recommended every 10 years

Fecal Occult Blood Test (FOBT) – recommended annually

Flexible Sigmoidoscopy – recommended every five years

1. North Dakota Statewide Cancer Registry 2. National Cancer Institute; Surveillance, Epidemiology, and End Results Program 3. North Dakota Department of Health, Vital Statistics 4. North Dakota Behavioral Risk Factor Surveillance System 5. 2012 North Dakota Survey of Endoscopic Capacity 6. 2013 North Dakota Burden of Cancer Report

Colorectal Cancer in North Dakota Statistics

Incidence

The average incidence rate of colorectal cancer in North Dakota for the years 2003-2012 is 50.9

cases per 100,000 population1

From 2003-2012, 3,934 new cases of colorectal cancer were diagnosed in North Dakota1

From 2002-2011, approximately 43 percent of all new cases of colorectal cancer were diagnosed

at a late stage in North Dakota1

Mortality

The average mortality rate of colorectal cancer in North Dakota for the years 2003-2011 is 17.2

cases per 100,000 population2

From 2003-2012, 1,375 people in North Dakota lost their lives to colorectal cancer3

The five-year survival rate for colorectal cancer if diagnosed in an early stage is 90 percent; that

rate drops to 13 percent if diagnosed at a late stage2

Screening

In 2012, the overall screening rate for those who are age-eligible (age 50-75) is 58.4 percent in

North Dakota4

In 2012, there were approximately 79,000 average-risk individuals 50 to 75 years of age who

remain unscreened for colorectal cancer5

Approximately 81 percent of colorectal cancer screening is performed with colonoscopy in

North Dakota5

Colonoscopy capacity is inadequate for all regions of North Dakota; the unmet need for

colonoscopy is 565 percent of the available unused capacity5

Costs

In 2010, approximately $31.1 million was spent on care related to colorectal cancer in North

Dakota6

Richard Wender, MD Chief Cancer Control Officer

American Cancer Society, Inc.

Dr. Richard Wender is the Chief Cancer Control Officer of the American Cancer Society, Inc. (ACS), a

position he assumed in November, 2013. This is a newly created position charged with providing

oversight and guidance for the national and global cancer control programs of ACS, including cancer

screening, tobacco control, access to care, and quality of life, in addition to providing high level

oversight for ACS’s global cancer control efforts.

For 34 years, Dr. Wender worked as a family physician in the Department of Family and Community

Medicine at Thomas Jefferson University in Philadelphia, Pa, serving as the Director of the Family

Medicine Residency Program from 1985 - 1995 and Vice Chair from 1995 – 2002. From 2002 until his

acceptance of his position at the ACS, Dr. Wender was the Alumni Professor and Chair of the

Department of Family and Community Medicine, a large, comprehensive department addressing the

tripartite mission of educating future health care professionals, conducting public health and health

services research, and improving care for all individuals living in the Philadelphia region through delivery

of primary care services and partnership with many community based organizations. During Dr.

Wender’s tenure, the Department also began developing a global health program. The ultimate mission

of the Department remains to improve health outcomes for all, with a particular focus on reducing

health disparities. Dr. Wender has held numerous other administration positions at Jefferson, including

serving as President and CEO of JeffCare, Thomas Jefferson University Hospital’s physician-hospital

organization and President and CEO of Jefferson Medical Care, a group of Hospital owned primary care

and specialty practices.

Dr. Wender has led numerous initiatives designed to improve preventive care and chronic disease

management, including being a pioneer in the Patient Centered Medical Home initiative. Much of this

work has focused on cancer prevention and control. He has served as an author of numerous scholarly

works including co-authoring several cancer screening guidelines. He is the first author on the recent

American Cancer Society lung cancer screening guideline. Dr. Wender currently serves as Chair of the

National Colorectal Cancer Roundtable, an organization consisting of close to 80 organizations dedicated

to eliminating colon cancer as a major public health problem.

Dr. Wender has received numerous awards and honors, including the Laurel for Cancer Prevention

Leadership from the Prevent Cancer Foundation and the St. George Medal from the American Cancer

Society. In 2006, Dr. Wender was elected as the national President of the American Cancer Society,

becoming the first primary care physician to serve in this capacity. While his new position will allow him

to have a greater impact on the cancer burden around the world, his roots remain grounded in primary

care, and he continues to provide primary care to patients at Jefferson. Through advocacy and through

constructing lasting partnerships, Dr. Wender remains committed to building bridges between public

health, community medicine, and primary care.

John Leitch MD is a medical oncologist and hospice/palliative medicine specialist at Sanford Roger Maris Cancer Center in Fargo, North Dakota. He is chair of the North Dakota Cancer Coalition He has been a member for ten years and assisted in the writing of the 201-2016 ND Cancer Plan. Dr. Leitch received his MD from the University of New Mexico School of Medicine in Albuquerque, New Mexico and is board certified in Internal Medicine, Medical Oncology, and Hospice/Palliative Medicine. He has practiced in Fargo at the Roger Maris Cancer Center for 24 years.

National Colorectal Cancer Roundtable Updated July 2014

80% by 2018 Fact Sheet

What is 80% by 2018? “80% by 2018” is a National Colorectal Cancer Roundtable initiative in which

dozens of organizations have committed to eliminating colorectal cancer as a major public health

problem and are working toward the shared goal of 80% of adults aged 50 and older being regularly

screened for colorectal cancer by 2018.

The National Colorectal Cancer Roundtable, an organization co-founded by the American Cancer Society

and the Centers for Disease Control and Prevention, is rallying organizations to embrace this shared

goal.

Why are organizations focusing on colorectal cancer?

Colorectal cancer is a major public health problem. Colorectal cancer is the third leading cause of cancer

death in both men and women in the U.S. and a cause of considerable suffering among more than

140,000 adults diagnosed with colorectal cancer each year. The good news is that when adults get

screened for colorectal cancer, it can be detected early at a stage when treatment is most likely to be

successful, and in some cases, it can be prevented through the detection and removal of precancerous

polyps. About 1 in 3 adults between 50 and 75 years old – about 23 million people -- are not getting

tested as recommended.

What will an 80% screening rate achieve?

Our organizations stand united in the belief that we can eliminate colorectal cancer as a major public

health problem. We can save thousands of lives by increasing screening rates to 80%. We know what

we need to do to get more people screened for colorectal cancer, prevent more cancers and save lives,

and we share a commitment to eliminating disparities in access to care. Our organizations will work to

empower communities, patients, health care providers, community health centers, and health systems

to close the screening gap.

What groups have committed to 80% by 2018?

Dozens of groups, including the American Cancer Society and the Centers for Disease Control and

Prevention, have committed to work together to increase the nation’s colon cancer screening rates and

embrace the goal of reaching 80% screened for colorectal cancer by 2018. Over a hundred

organizations, including medical professional societies, non-profits, health plans, government, health

departments, survivors, cancer coalitions and medical practices, have embraced the goal. The number is

growing every day. Achieving an 80 percent screening rate by 2018 will require the collaboration of

many leaders; it cannot be achieved working in isolation. Health care providers, health systems,

communities, businesses, community health centers, government, and every day Americans all have a

role to play.

National Colorectal Cancer Roundtable Updated July 2014

With so many other competing needs, why now?

Most importantly, we know screening is working. Colon cancer incidence rates have dropped 30

percent in the U.S. in the last 10 years among adults 50 and older. In the simplest terms, this means

people aren’t developing colon cancer at the same high rate as the past, because more people have

been getting screened. The percentage of the population up-to-date with recommended colorectal

cancer screening increased from 56 percent in 2002 to 65 percent in 20101. On top of that, the

healthcare landscape is changing and barriers to colorectal cancer screening are breaking down. More

people now have coverage for colorectal cancer screening than ever before. Top health systems already

are achieving 80% screening rates. Massachusetts is already screening over 76% of their eligible

population, the highest screening rate in the nation. An 80% screening rate is achievable. Now is the

time to work together to reach an 80 percent colorectal cancer screening rate by 2018.

Who is not getting screened?

Across our nation significant disparities exist but we are committed to eliminating these disparities. The

people less likely to get tested are Hispanics, American Indians or Alaska Natives, rural populations,

men, those 50 to 64, and those with lower education and income. Patients and providers do not always

know about or consider all the available recommended screening tests, and currently, most health care

providers and systems are not set up to help more people get screened for colorectal cancer. Screening

saves lives, but only if people get tested. There are several recommended screening test options,

including: colonoscopy, stool tests (guaiac fecal occult blood test [gFOBT] or fecal immunochemical test

[FIT]), and sigmoidoscopy. The best test is the one that gets done.

What is an organization committing to if they embrace the goal?

At the most basic level, an organization is committing to investing more energy in increasing colorectal

cancer screening rates than they did before. Part of the 80 percent by 2018 goal is to leverage the

energy of multiple and diverse committed partners to make history and achieve this remarkable public

health goal. By working together, demanding more of ourselves, and collectively pushing harder

toward this common goal, we will make greater progress, prevent more cancers, and save more lives

than we would by acting alone.

How can an organization be a part of the 80% by 2018 effort?

Go to nccrt.org/about/80-percent-by-2018/80-percent-by-2018-pledge and sign up on line!

1 Morbidity and Mortality Weekly Report: Vital Signs: Colorectal Cancer Screening Test Use — United States,

2012. Centers for Disease Control and Prevention. November 5, 2013. Vol. 62

FOR IMMEDIATE RELEASE FOR MORE INFORMATION, CONTACT:

Shannon Bacon, Health Systems Manager Janna Pastir, Program Director, Comprehensive Cancer Control American Cancer Society North Dakota Department of Health Phone: 701-433-7593 Phone: 701.328.3046 Email: shannon.bacon@cancer.org Email: jlpastir@nd.gov

American Cancer Society Chief Cancer Control Officer Dr. Richard Wender to Keynote North Dakota Cancer Coalition Conference

May 19 at Baymont Inn and Suites, Mandan Mandan, ND. (May 5) – American Cancer Society Chief Cancer Control Officer Dr. Richard Wender is set to keynote the North Dakota Cancer Coalition Annual Conference on Tuesday, May 19, from 8 a.m. to 4:40 p.m. at Baymont Inn and Suites, Mandan. Barbara Sheets Olson, MD, Family Medical Clinic, Lisbon, ND; and Jodie Fetsch, RN, Director of Nursing, Custer Health, Mandan, ND, will also bring their expertise to the program. Recognized for his oversight and guidance for the national and global cancer control programs of the Society, Dr. Wender serves as Chair of the National Colorectal Cancer Roundtable. Colorectal cancer is the second-leading cause of cancer death in the United States, but incidence and mortality rates can be reduced with screening. North Dakota ranks 46 out of 51 states (including the District of Columbia) for up-to-date colorectal cancer screenings. “The number of colon cancer cases and deaths has been dropping rapidly for over a decade and now is the right time to accelerate our progress by convening all key stakeholders to rapidly and dramatically increase screening rates to reach our national goal of having 80 percent of eligible individuals up to date with screening by the end of 2018,” said Dr. Wender. “This event is going to catalyze progress towards reaching the 80 percent goal. The American Cancer Society is honored and thrilled to be able to partner in this critically important meeting.” A collaborative effort among health-related organizations from throughout the state, the North Dakota Cancer Coalition and American Cancer Society are leading this conference which is dedicated to reducing the incidence of and mortality from colorectal cancer in North Dakota through coordinated leadership, strategic planning and advocacy. The conference is open to anyone in the state who has a desire to help save lives from colon cancer in North Dakota by increasing the number of people who are screened for the disease. Registration closes on Friday, May 8. The Conference will include key stakeholders such as physicians, nurse practitioners/physician assistants, hospitals, Indian Health Services (IHS), quality improvement organizations, industry groups, and Federally Qualified Health Centers from around the state. Attendees will participate in breakout sessions:

How to Increase Colorectal Screening Rates in Practice

Quality Care-Palliative Care in Cancer

Cancer Survivorship: Plans, Physical and Mental Health

Physical Activity Interventions at Worksite, School, and Community Levels

Charged with increasing the use of proven colorectal cancer screening tests among North Dakota’s entire population for whom screening is appropriate, the conference has the opportunity to make a greater impact on colorectal cancer through a united effort, promoting the education and awareness of colorectal cancer for patients and providers, reducing barriers to colorectal cancer screening through policy and advocacy, ultimately contributing to the nation’s 80% by 2018 colon cancer initiative. North Dakota is uniquely positioned to create meaningful change now with the recent implementation of the Affordable Care Act and the ongoing investment of health systems partners statewide to increase colorectal cancer screening. This means more North Dakotans have medical coverage and can act on preventative services rather than costly treatment. About the American Cancer Society The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organization, the Society's efforts have contributed to a 20 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates. Thanks in part to our progress nearly 14 million Americans who have had cancer and countless more who have avoided it will celebrate more birthdays this year. As we celebrate our 100th year of service, we're determined to finish the fight against cancer. We're finding cures as the nation’s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, clean air, and more. For more information, to get help, or to join the fight, call us anytime, day or night, at 1-800-227-2345 or visit www.cancer.org/fight .

###